Summary
The pharmaceutical industrys giants succeeded last year in shifting some of the concerns about drug pricing onto pharmacy benefit managers, while publicly agreeing with the White House to lower some prices. These splashy announcements helped create the illusion that action had been taken to help Am…
Source: BioSpace
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
